Stockreport

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

Oculis Holding AG - Ordinary shares  (OCS) 
PDF ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focuse [Read more]